Advertisement

PharmacoEconomics

, Volume 8, Issue 4, pp 282–290 | Cite as

Do Physicians Take Cost Into Account When Making Prescribing Decisions?

  • Petra Denig
  • Flora M. Haaijer-Ruskamp
Leading Article

Keywords

Drug Cost Alteplase Clinical Pharmacist Hospital Physician Expensive Drug 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Parish PA. Drug prescribing — the concern of all. R Soc Health 1973; 4: 213–7CrossRefGoogle Scholar
  2. 2.
    Dukes MNG. Rational use of drugs: an overview. In: Muller NF, Hekster YA, editors. Progress in clinical pharmacy 1989: rational use of drugs. Noordwijk: Amsterdam Medical Press BV, 1990: 3–18Google Scholar
  3. 3.
    Audit Commission. A prescription for improvement: towards more rational prescribing in general practice. London: Her Majesty’s Stationery Office, 1994Google Scholar
  4. 4.
    Chew R, Griffin JP. Growth in prescription medicine expenditure: an international comparison of the nature of growth [briefing]. London: Association of the British Pharmaceutical Industry, 1992 JulGoogle Scholar
  5. 5.
    Denig P. Drug choice in medical practice: rationales, routines, and remedies [dissertation]. Groningen: University of Groningen, 1994Google Scholar
  6. 6.
    Tonks A. GPs’ prescribing is irrational, says Audit Commission [editorial]. BMJ 1994; 308: 675CrossRefGoogle Scholar
  7. 7.
    Soumerai SB, Ross-Degnan D, Forless EE, et al. A critical analysis of studies of state drug reimbursement policies: research in need of discipline. Milbank Q 1993; 71: 217–52PubMedCrossRefGoogle Scholar
  8. 8.
    Ryan M, Yule B. The way to economic prescribing. Health Policy 1993; 25: 25–38PubMedCrossRefGoogle Scholar
  9. 9.
    Walzak D, Swindells S, Bhardwaj A. Primary care physicians and the cost of drugs: a study of prescribing practices based on recognition and information sources. J Clin Pharmacol 1994; 34: 1159–63PubMedGoogle Scholar
  10. 10.
    Johnstone RE, Jozefczyk KG. Costs of anesthetic drugs: experiences with cost education trial. Anesth Analg 1994; 78: 766–71PubMedGoogle Scholar
  11. 11.
    Kane RL, Garrard J. Changing physician prescribing practices: regulation vs education. JAMA 1994; 271: 393–4PubMedCrossRefGoogle Scholar
  12. 12.
    Zelnio RN. The interaction among the criteria physicians use when prescribing. Med Care 1982; 20: 277–85PubMedCrossRefGoogle Scholar
  13. 13.
    Denig P, Haaijer-Ruskamp FM, Zijsling DH. How physicians choose drugs. Soc Sci Med 1988; 27: 1381–6PubMedCrossRefGoogle Scholar
  14. 14.
    Janknegt R, Steenhoek A. Keuzecriteria voor geneesmiddelen bij een ’eenvoudige cystitis’. Tijdschr Ther Geneesm Onderz 1988; 13: 204–8Google Scholar
  15. 15.
    Janknegt R, Smelik J, Steenhoek A. Betablokkers: keuzecriteria en produktvoorkeur Resultaten van een onderzoek bij vijftig artsen. Pharm Weekbl 1990; 125: 676–80Google Scholar
  16. 16.
    Segal R, Hepler CD. Prescribers’ beliefs and values as predictors of drug choices. Am J Hosp Pharm 1982; 39: 1391–7Google Scholar
  17. 17.
    Shulkin D. The rising cost of pharmaceuticals: a physician’s perspective. Am J Hosp Pharm 1993; 50 Suppl. 4: S8–1OGoogle Scholar
  18. 18.
    Ryan M, Yule B, Bond C, et al. Scottish general practitioners’ attitudes and knowledge in respect of prescribing costs. BMJ 1990; 300: 1316–8PubMedCrossRefGoogle Scholar
  19. 19.
    Savafi KT, Hayward RA. Choosing between apples and apples: physicians’ choices of prescription drugs that have similar side effects and efficacies. J Gen Intern Med 1992; 7: 32–7CrossRefGoogle Scholar
  20. 20.
    Denig P, Haaijer-Ruskamp PM, Wesseling H, et al. Towards understanding treatment preferences of hospital physicians. Soc Sci Med 1993; 36: 915–24PubMedCrossRefGoogle Scholar
  21. 21.
    Chinburapa V, Larson LN. The importance of side effects and outcomes in differentiating between prescription drug products. J Clin Pharm Ther 1992; 17: 333–42PubMedCrossRefGoogle Scholar
  22. 22.
    Chinburapa V, Larson LN. Predicting prescribing intention and assessing drug attribute importance using conjoint analysis. J Pharm Market Manage 1988; 3: 3–18CrossRefGoogle Scholar
  23. 23.
    Segal R, Hepler CD. Drug choice as a problem solving process. Med Care 1985; 23: 967–76PubMedCrossRefGoogle Scholar
  24. 24.
    Epstein AM, Read JL, Winickoff R. Physician beliefs, attitudes and prescribing behavior for anti-inflammatory drugs. Am J Med 1984; 77: 313–8PubMedCrossRefGoogle Scholar
  25. 25.
    Freeman JK, Barnes JH, Summers KH, et al. Modeling physicians’ prescribing decisions for patients with panic disorder. J Health Care Marketing 1993; 5: 34–9Google Scholar
  26. 26.
    Svenson O. Process descriptions of decision making. Org Behav Human Perform 1979; 23: 86-ll2CrossRefGoogle Scholar
  27. 27.
    Billings RS, Marcus SA. Measures of compensatory and noncompensatory models of decision behavior: process tracing versus policy capturing. Org Behav Hum Perform 1983; 31: 331–52CrossRefGoogle Scholar
  28. 28.
    Moskowitz AJ, Kuipers BJ, Kassirer JB. Dealing with uncertainty, risks and tradeoffs in clinical decisions: a cognitive science approach. Ann Intern Med 1988; 108: 435–49PubMedGoogle Scholar
  29. 29.
    Elstein AS, Holzman GB, Belzer LJ, et al. Hormonal replacement therapy: analysis of clinical strategies used by residents. Med Decis Making 1992; 12: 265–73PubMedCrossRefGoogle Scholar
  30. 30.
    Chinburapa V, Larson LN, Brucks M, et al. Physician prescribing decisions: the effects of situational involvement and task complexity on information acquisition and decision making. Soc Sci Med 1993; 36: 1473–82PubMedCrossRefGoogle Scholar
  31. 31.
    Denig P, Haaijer-Ruskamp PM, Wesseling H, et al. Drug expectations and drug choices of hospital physicians. J Intern Med 1993; 234: 155–63PubMedCrossRefGoogle Scholar
  32. 32.
    Brody B, Wray N, Bame S, et al. The impact of economic considerations on clinical decision making: the case of thrombolytic therapy. Med Care 1991; 29: 899–910PubMedCrossRefGoogle Scholar
  33. 33.
    Sherry S, Marder VJ. Creation of the recombinant tissue plasminogen activator (rt-PA) image and its influence on practice habits. J Am Coli Cardiol 1991; 18: 1579–82CrossRefGoogle Scholar
  34. 34.
    Zelnio RN, Gagnon JP. The effects of price information on physician prescribing patterns. Drug Intell Clin Pharm 1979; 13: 156–9PubMedGoogle Scholar
  35. 35.
    Yule B, Ryan M, Bond C, et al. Awareness of drug costs among general practitioner trainees. Med Educ 1991; 25: 536–8PubMedCrossRefGoogle Scholar
  36. 36.
    Greene HL, Goldberg RJ, Beattie H, et al. Physician attitudes toward cost containment: the missing piece of the puzzle. Arch Intern Med 1989; 149: 1966–8PubMedCrossRefGoogle Scholar
  37. 37.
    Ryan M, Yule B, Bond C, et al. Knowledge of drug costs: a comparison of general practitioners in Scotland and England. Br J Gen Pract 1992; 42: 6–9PubMedGoogle Scholar
  38. 38.
    Denig P, Haaijer-Ruskamp PM, Wesseling H, et al. Prescriptie onderzoek. Deel 2: analyse van therapiekeuzen. Groningen: Northern Centre for Healthcare Research, 1991Google Scholar
  39. 39.
    Eisenberg JM. Cost containment and changing physician behavior. JAMA 1981; 246: 2195–201PubMedCrossRefGoogle Scholar
  40. 40.
    Soumerai SB, Avorn J. Efficacy and cost-containment in pharmacotherapy. Milbank Mem Fund Q 1984; 62: 447–74CrossRefGoogle Scholar
  41. 41.
    Schroeder SA. Strategies for reducing medical costs by changing physicians’ behavior: efficacy and impact on quality of care. Int J Technol Assess Health Care 1987; 3: 35–50CrossRefGoogle Scholar
  42. 42.
    Lomas J, Haynes RB. A taxonomy and critical review of tested strategies for the application of clinical practice recommendations: from ‘official’ to ‘individual’ clinical policy. Am J Prev Med 1988; 4: 77–94PubMedGoogle Scholar
  43. 43.
    Soumerai SB, McLaughlin TJ, Avorn J. Improving drug prescribing in primary care: a critical analysis of the experimental literature. Milbank Q 1989; 67: 268–317PubMedCrossRefGoogle Scholar
  44. 44.
    Harris JS. Why doctors do what they do: determinants of physician behavior. J Occup Med 1990; 32: 1207–20PubMedCrossRefGoogle Scholar
  45. 45.
    Greco PJ, Eisenberg JM. Changing physician’s practices. N Engl J Med 1993; 329: 1271–4PubMedCrossRefGoogle Scholar
  46. 46.
    Babington MA, Robinson LA, Monson RA. Effect of written information on physicians’ knowledge of drug prices. South Med J 1983; 76: 328–34PubMedCrossRefGoogle Scholar
  47. 47.
    Hershey CO, Goldberg MI, Cohen DI. The effect of computerized feedback coupled with a newsletter upon outpatient prescribing charges. Med Care 1988; 26: 88–94PubMedCrossRefGoogle Scholar
  48. 48.
    Steele MA, Bess DT, Franse VL, et al. Cost effectiveness of two interventions for reducing outpatient prescribing costs. DICP Ann Pharmacother 1989; 23: 497–500Google Scholar
  49. 49.
    Erramouspe J. Impact of education by clinical pharmacists on physician ambulatory care prescribing of generic versus brand-name drugs. mcp Ann Pharmacother 1989; 23: 770–3Google Scholar
  50. 50.
    Hershey CO, Porter DK, Breslau D, et al. Influence of simple computerized feedback on prescribing charges in an ambulatory clinic. Med Care 1986; 24: 472–81PubMedCrossRefGoogle Scholar
  51. 51.
    Frazier LM, Brown JT, Divine GW, et al. Can physician education lower the cost of prescription drugs? A prospective, controlled trial. Ann Intern Med 1991; ll5: ll6–21Google Scholar
  52. 52.
    Forstrom MJ, Ried LD, Stergachis AS, et al. Effect of a clinical pharmacist program on the cost of hypertension treatment in an HMO family practice clinic. mcp Ann Pharmacother 1990; 24: 304–9Google Scholar
  53. 53.
    Stergachis A, Fors M, Wagner PH, et al. Effects of clinical pharmacists on drug prescribing. Am J Hosp Pharm 1987; 44: 525–8PubMedGoogle Scholar
  54. 54.
    Buckley G, Allen J. Can rational prescribing be summatively assessed? In: Kochen MM, editor. Drug education in general practice. Occasional Paper 69. Exeter (England): Royal College of General Practitioners, 1995Google Scholar
  55. 55.
    Manheim LM, Feinglass J, Hughes R, et al. Training house officers to be cost conscious: effects of an educational intervention on charges and length of stay. Med Care 1990; 28: 29–40PubMedCrossRefGoogle Scholar
  56. 56.
    Beardon P, Brown S, Mowatt D, et al. Introducing a drug formulary to general practice — effects on practice prescribing costs. J R Coli Gen Pract 1987; 37: 305–7Google Scholar
  57. 57.
    Baker JA, Lant AF, Sutters CA. Seventeen years’ experience of a voluntarily based drug rationalisation programme in hospital. BMJ 1988; 297: 465–9PubMedCrossRefGoogle Scholar
  58. 58.
    Wyatt TD, Reilly PM, Morrow NC, et al. Short-lived effects of a formulary on anti-infective prescribing — the need for continuing peer review? Fam Pract 1992; 9: 461–5PubMedCrossRefGoogle Scholar
  59. 59.
    Field J. How do doctors and patients react to the introduction of a practice formulary? Fam Pract 1989; 6: 135–40PubMedCrossRefGoogle Scholar
  60. 60.
    Feely J, Chan R, Cocoman L, et al. Hospital formularies: need for continuous intervention. BMJ 1990; 300: 28–30PubMedCrossRefGoogle Scholar
  61. 61.
    Shenfield L, Jones AN. Effects of restrictions on prescribing patterns for dextropropoxyphene. BMJ 1980; 281: 651–3PubMedCrossRefGoogle Scholar
  62. 62.
    Post D. Wijzigingen in de prescriptie: het effect van de oktoberen februarimaatregel. Med Contact 1984; 39: 19–21Google Scholar
  63. 63.
    Soumerai SB, Ross-Degnan D, Gortmaker S, et al. Withdrawing payment for nonscientific drug therapy: intended and unexpected effects of a large-scale natural experiment. JAMA 1990; 263: 831–9PubMedCrossRefGoogle Scholar
  64. 64.
    Weintraub M, Singh S, Byrne L, et al. Consequences of the 1989 New York State triplicate benzodiazepine prescription regulations. JAMA 1991; 266: 2392–7PubMedCrossRefGoogle Scholar
  65. 65.
    Wo haben die Kassenarzte gespart? Arzneimittelbrief 1993; 27: 62–3Google Scholar
  66. 66.
    Maxwell M, Howie JGR. Can feedback on prescribing be integrated into continuing medical education? In: Kochen MM, editor. Drug education in general practice. Occasional Paper 69. Exeter (England): Royal College of General Practitioners, 1995Google Scholar
  67. 67.
    Forbes J. Practice budgets: lifting the veil of ignorance. J R Coll Gen Pract 1989; 39: 355–8PubMedGoogle Scholar
  68. 68.
    Wetchler BV. Economic impact of anesthesia decision-making: they pay the money, we make the choice. J Clin Anesth 1992; 4: 20–4CrossRefGoogle Scholar
  69. 69.
    Bandyopadhyay D. Rational prescribing takes time [letter]. BMJ 1994; 308: 977CrossRefGoogle Scholar
  70. 70.
    Taylor RJ, Bond CM. Change in the established prescribing habits of general practitioners: an analysis of initial prescriptions in general practice. Br J Gen Pract 1991; 41: 244–8PubMedGoogle Scholar
  71. 71.
    Ferguson RP, Wetle T, Dubitzky D, et al. Relative importance to elderly patients of effectiveness, adverse effects, convenience and cost of antihypertensive medications. Drugs Aging 1994; 4: 56–62PubMedCrossRefGoogle Scholar

Copyright information

© Adis International Limited 1995

Authors and Affiliations

  • Petra Denig
    • 1
  • Flora M. Haaijer-Ruskamp
    • 2
  1. 1.Northern Centre for Healthcare ResearchUniversity of GroningenGroningenThe Netherlands
  2. 2.Department of Health SciencesUniversity of GroningenGroningenThe Netherlands

Personalised recommendations